Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of Mr. D. Scott Mackesy and Resignation of Mr. Anthony J. DeNicola from the Board of Directors
On December 2, 2022, the Board of Directors (the “Board”) of Clearwater Analytics Holdings, Inc. (the “Company”) appointed Mr. D. Scott Mackesy to the Board, effective on December 5, 2022. Additionally, the Board appointed Mr. Mackesy to serve as a member of the Compensation Committee of the Board, effective on December 5, 2022. Mr. Mackesy will succeed Mr. Anthony J. DeNicola, who will resign as a director of the Board and a member of the Compensation Committee of the Board effective on December 5, 2022. Mr. Mackesy will serve as a Class II director of the Board and as a member of the Compensation Committee of the Board until the Company’s Annual Meeting of Stockholders in 2023 and until his successor shall have been duly elected and qualified.
Mr. Mackesy will not be compensated for his service on the Board and on the Compensation Committee of the Board, but will be reimbursed for all reasonable out-of-pocket expenses related to his service.
Mr. Mackesy, 54, is the managing partner of Welsh, Carson, Anderson & Stowe (“WCAS”) and is a member of its management committee, having joined WCAS in 1998. Mr. Mackesy focuses on overall firm strategy at WCAS. Prior to joining WCAS, Mr. Mackesy worked for six years at Morgan Stanley Dean Witter in the Investment Research Department, where he was responsible for coverage of the healthcare services sector. Mr. Mackesy holds a Bachelor of Arts degree from the College of William & Mary.
WCAS is a principal equity owner of the Company and Mr. Mackesy was appointed to the Board pursuant to WCAS’ director nomination rights under that certain Stockholders’ Agreement (the “Stockholders’ Agreement”), dated as of September 28, 2021, by and among the Company and the principal equity owners party thereto. The Stockholders’ Agreement and certain other relationships and related party transactions between the Company and WCAS are described in the section titled “Certain Relationships and Related Party Transactions” in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2022, and such information is incorporated herein by reference.
Other than as described above, there are no arrangements or understandings between Mr. Mackesy and any other persons pursuant to which Mr. Mackesy was appointed as a director of the Board and a member of the Compensation Committee of the Board and Mr. Mackesy does not have a direct or indirect material interest in any related party transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no family relationships between Mr. Mackesy and any director or executive officer of the Company.
In connection with Mr. Mackesy’s appointment to the Board, the Company intends to enter into an indemnification agreement with Mr. Mackesy in substantially the same form as the Company has entered into with each of the Company’s existing directors and as previously disclosed in the Company’s public filings.